Filing Details

Accession Number:
0001179110-21-008871
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-09-21 14:06:46
Reporting Period:
2021-09-20
Accepted Time:
2021-09-21 14:06:46
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1428336 Healthequity Inc. HQY () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1179972 G Darcy Mott C/O Healthequity, Inc.
15 W. Scenic Pointe Dr., Ste. 100
Draper UT 84020
No No No Yes
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-09-20 10,000 $14.00 97,052 No 4 M Direct
Common Stock Disposition 2021-09-20 5,665 $62.00 91,387 No 4 S Direct
Common Stock Disposition 2021-09-20 335 $62.97 91,052 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2021-09-20 10,000 $0.00 10,000 $14.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
20,000 2024-07-30 No 4 M Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Option (right to buy) $25.39 2025-03-26 25,000 25,000 Direct
Common Stock Stock Option (right to buy) $41.28 2027-03-27 19,897 19,897 Direct
Common Stock Stock Option (right to buy) $61.72 2028-03-27 14,228 14,228 Direct
Common Stock Stock Option (right to buy) $73.61 2029-03-26 15,337 15,337 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2025-03-26 25,000 25,000 Direct
2027-03-27 19,897 19,897 Direct
2028-03-27 14,228 14,228 Direct
2029-03-26 15,337 15,337 Direct
Footnotes
  1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.53 to $62.51, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) of this Form 4.
  3. The option is immediately exercisable.
  4. The option is exercisable as to 10,671 shares. The remaining 3,557 options vest on March 27, 2022.
  5. The option is exercisable as to 7,669 shares. The remaining options vest as to 3,834 shares on each of March 27, 2022 and 2023.